Prelude Capital Management’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Prelude Capital Management’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,057	Closed	-$2K	–	1719
2022 Q3	$2K	Hold	14,057	–	–	﹤0.01%	1442
2022 Q2	$1K	Hold	14,057	–	–	﹤0.01%	1764
2022 Q1	$2K	Hold	14,057	–	–	﹤0.01%	1733
2021 Q4	$3K	Hold	14,057	–	–	﹤0.01%	1960
2021 Q3	$3K	Hold	14,057	–	–	﹤0.01%	1670
2021 Q2	$4K	Buy	+14,057	New	+$2.9K	﹤0.01%	1614

Other funds holding VHAQ.RT

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Prelude Capital Management's VHAQ.RT Position: Q4 2022 in Review

Prelude Capital Management sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q4 2022, closing a stake of 14,057 shares — an estimated $2K sold.

Prelude Capital Management first reported a position in VHAQ.RT in Q2 2021 and held it in 6 quarters. The position peaked at $4K in Q2 2021. 27 funds tracked by Wall St. Rank hold VHAQ.RT as of Q4 2022.

Prelude Capital Management reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 14,057 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q4 2022, an estimated $2K.
Prelude Capital Management first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q2 2021 and held it in 6 quarters.
Prelude Capital Management's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $4K in Q2 2021.
27 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.